National Strategic Plan on Antimicrobial Resistance (2018-2020).

National Strategic Plan on Antimicrobial Resistance (2018-2020) is a cross-sectoral policy document. The vision is: - To promote public awareness campaign on AMR emergence and spreading. - To improve the rational use of antimicrobial medicines which are accessible to the public. - To prevent emergence of antimicrobial resistance ensuring the rational use of antimicrobial medicines as well as the appropriate mobilization of other resources. - To bring behavioral changes toward the rational use of antimicrobial medicines among the professionals in public health sector and the population. - To ensure effective prevention and containment of antimicrobial medicines through renovation, development of new medicines along with the prompt introduction to the public population. - To ensure one health engagement involving public health, veterinary and fishery sectors to bring effective prevention and control of AMR in collaboration with relevant sectors. The overall goal of the Policy is to ensure, for as long as possible, continuity of the ability to treat and prevent infectious diseases with effective and safe medicines that are quality-assured, used in a responsible way, and accessible to all who need them.
To achieve this overall goal, five strategic objectives have been identified: 1. Improve awareness and understanding of AMR through education and training 2 Strengthen knowledge and evidence base through surveillance and research 3. Reduce the incidence of infection through effective hygiene and IPC measures 4. Optimize the use of antimicrobial medicines in human and animal health 5. Ensure sustainable investment through research and development. Under each of the five strategic areas, the Policy proposes several strategic interventions, which include: Formation of national AMR steering committee; Include AMR and related topics as core component for professional training in the field of health, veterinary and agricultural practices; Strengthen the political/administrative commitment to AMR through the formation of AMR sub-committee; Development of guideline on AMR incorporating both of human and non-human sectors;Strengthen the capacity of laboratory to provide with AMR-related evidences; Foster environment on facilitation of traditional medicine; Strenthen knowledge on AMR through research; Ensure evidence-based prescribing and dispensing of antimicrobial medicines; Establish data-base on side-effects from drug use; Measure the economic impact from AMR burden; etc.